Aging Aging

376 AndersenPower, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J.,Wadsworth, S., Wolozin, B., and Zhao, J. (1995) Alzheimer-type neuropathologyin transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature373, 523–527.54. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. M., Perez-tur, J., Hutton, M.,Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M. N., Holcomb, L., Refolo,L., Zenk, B., Hardy, J., and Younkin, S. (1996) Increased amyloid-beta42(43) inbrains of mice expressing mutant presenilin 1. Nature 383, 710–713.55. Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright,K., Saad, I., Mueller, R., Morgan, D., Sanders, S., Zehr, C., O’Campo, K., Hardy, J.,Prada, C. M., Eckman, C., Younkin, S., Hsiao, K., and Duff, K. (1998) AcceleratedAlzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursorprotein and presenilin I transgenes. Nat. Med. 4, 97–100.56. Duff, K. (1997) Alzheimertransgenic mouse models come of age. Trends Neurosci.20, 279–280.57. Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu,S., Eckman, C., Younkin, S., and Price, D. (1995) Age-related CNS disorder andearly death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursorproteins. Neuron 15, 1203–1218.58. Haynes, L., Linton, P. J., and Swain, S. L. (1997) Age-related changes in CDC4 Tcells of T cell receptor transgenic mice. Mech. Ageing Dev. 93, 95–105.59. Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., and Ross, R. (1994)ApoE-deficient mice develop lesions of all phases of atherosclerosis throughoutthe arterial tree. Arteriosclerosis Thromb. 14, 133–140.60. Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., and Witztum, J.L. (1994) ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis.Demonstration of oxidation-specific epitopes in lesions and high titers ofautoantibodies to malondialdehyde-lysine in serum. Arteriosclerosis Thromb. 14,605–616.61. Bellosta, S., Mahley, R. W., Sanan, D. A., Murata, J., Newland, D. L., Taylor, J. M.,and Pitas, R. E. (1995) Macrophage-specific expression of human apolipoprotein Ereduces atherosclerosis in hypercholesterol emi c apolipoprotei n E-null mice. J. Clin.Invest. 96, 2170–2179.62. van Vlijmen, B. J., van den Maagdenberg, A. M., Gijbels, M. J., van der Boom, H.,HogenEsch, H., Frants, R. R., Hofker, M. H., and Havekes, L. M. (1994) Dietinducedhyperlipoproteinemi a and atherosclerosis in apolipoprotein E3*-Leidentransgenic mice. J. Clin. Invest. 93, 4 1403–41410.63. Fazio, S., Horie, Y., Simonet, W. S., Weisgraber, K. H., Taylor, J. M., and Rall, S.C., Jr. (1994) Altered lipoprotein metabolism in transgenic mice expressing lowlevels of a human receptor-binding-defective apolipoprotein E. J. Lipid Res. 35,408–416.64. van Vlijmen, B. J., van Dijk, K. W., van’t Hof, H. B., van Gorp, P. J., van der Zee,A., van der Boom, H., Breuer, M. L., Hofker, M. H., and Havekes, L. M. (1996) hrthe absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-l58